Q4 Results News

Jewellery Stock Posts Strong Q4 FY25 Results; Swings To Rs 95 Cr Profit, Revenue Soars 1356%

Jewellery Stock Posts Strong Q4 FY25 Results; Swings To Rs 95 Cr Profit, Revenue Soars 1356%

Listed 5 Months Ago: Small-Cap Stock Reports Robust FY25 Performance, Strategic Growth Milestones

Listed 5 Months Ago: Small-Cap Stock Reports Robust FY25 Performance, Strategic Growth Milestones

One Point One Solutions Q4 Results: Net Profit Skyrockets 55%; Revenue Exceed Expectations For FY25

One Point One Solutions Q4 Results: Net Profit Skyrockets 55%; Revenue Exceed Expectations For FY25

Q4 Results This Week: LIC, Bosch, Bajaj, IRCTC, Nykaa Among 1,500 Companies to Announce Earnings in May End

Q4 Results This Week: LIC, Bosch, Bajaj, IRCTC, Nykaa Among 1,500 Companies to Announce Earnings in May End

Glenmark Pharma Returns to Profit in Q4 FY25, Posts Rs 1,389 Crore Annual PAT, Declares Final Dividend

Glenmark Pharma Returns to Profit in Q4 FY25, Posts Rs 1,389 Crore Annual PAT, Declares Final Dividend

Penny Stock Trading Near Rs 1.50 Hits 5% Upper Circuit On Eyeing Rs 250 Million Expansion Into Distilleries

Penny Stock Trading Near Rs 1.50 Hits 5% Upper Circuit On Eyeing Rs 250 Million Expansion Into Distilleries

IMFA Q4 FY25 Results: Annual Profit Climbs to Rs. 378 Cr, Revenue Dips Slightly; Expansion Plans on Track

IMFA Q4 FY25 Results: Annual Profit Climbs to Rs. 378 Cr, Revenue Dips Slightly; Expansion Plans on Track

Penny Stock Trading Under Rs 30 To Declare Q4 Results & Dividend On This Date; Do You Own?

Penny Stock Trading Under Rs 30 To Declare Q4 Results & Dividend On This Date; Do You Own?

Mankind Pharma Q4 Result 2025: Net Profit Falls 10.7% to Rs 420.8 Crore, Revenue Jumps 27%, EBITDA Rises 16.5%

Mankind Pharma Q4 Result 2025: Net Profit Falls 10.7% to Rs 420.8 Crore, Revenue Jumps 27%, EBITDA Rises 16.5%

Mukul Agrawal Stock + Multibagger IPO: Siyaram Recycling Reports FY25 Results: Net Profit Surges 94% YoY

Mukul Agrawal Stock + Multibagger IPO: Siyaram Recycling Reports FY25 Results: Net Profit Surges 94% YoY

Ashish Kacholia Portfolio: Specialty Chemical Stock Declares Q4 Results & Final Dividend For FY25

Ashish Kacholia Portfolio: Specialty Chemical Stock Declares Q4 Results & Final Dividend For FY25

BSE 500 Stock Up 42% YTD, Q4 Profit Soars 183% YoY: What's Next Before A Breakout?

BSE 500 Stock Up 42% YTD, Q4 Profit Soars 183% YoY: What's Next Before A Breakout?

Construction Stock Reports 50.23% Jump In Q4 Net Profit; Total Sales At Rs 2,251 Cr In FY25

Construction Stock Reports 50.23% Jump In Q4 Net Profit; Total Sales At Rs 2,251 Cr In FY25

Gland Pharma Q4 Results 2025 Preview: Steady Growth Expected on Strong US Sales, New Launches; Share Price Up

Gland Pharma Q4 Results 2025 Preview: Steady Growth Expected on Strong US Sales, New Launches; Share Price Up

Portfolio Stock of Mukul Agrawal & Ashish Kacholia Hits 6th Straight Upper Circuit After Strong H2FY25 Results

Portfolio Stock of Mukul Agrawal & Ashish Kacholia Hits 6th Straight Upper Circuit After Strong H2FY25 Results

Over 1,055% Returns In 5 Yrs: BSE Small-Cap Metal Stock To Deliver Q4 Results On May 26 With Final Dividend

Over 1,055% Returns In 5 Yrs: BSE Small-Cap Metal Stock To Deliver Q4 Results On May 26 With Final Dividend

Q4 Results Next Week: ITC, Hindalco, Pfizer, Power Grid, IndusInd Bank, RVNL, JSW Steel, And More

Q4 Results Next Week: ITC, Hindalco, Pfizer, Power Grid, IndusInd Bank, RVNL, JSW Steel, And More

Q4 Disappoints, But 150% Dividend Surprise: Technical Setup Turns Bullish; How To Trade Dollar Industries?

Q4 Disappoints, But 150% Dividend Surprise: Technical Setup Turns Bullish; How To Trade Dollar Industries?

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+